|
|
||||||||
From the Departments of Neurology (Drs. Mega and Cummings, and T. Fiorello) and Psychiatry and Biobehavioral Science (Dr. Cummings), UCLA School of Medicine; Behavioral Neuroscience Section (Dr. Cummings), Psychiatry Service, West Los Angeles Veterans Affairs Medical Center; and the Biomathematical Consulting Unit, Department of Biomathematics (Dr. Gornbein), UCLA School of Medicine, Los Angeles, CA.
Supported by the Department of Veteran's Affairs, a National Institute on Aging Alzheimer's Disease Center (AG 10123), and the Helga and Irving Cooper Award of the UCLA Center on Aging.
Received January 12, 1995. Accepted in final form April 26, 1995.
Address correspondence and reprint requests to Dr. Jeffrey L. Cummings, Neurobehavior Unit (Bldg 256b; 116AF), West LA VAMC, 11301 Wilshire Blvd, Los Angeles, CA 90073.
Article abstract-We investigated the range of behavioral abnormalities in patients with Alzheimer's disease (AD) compared with normal age-matched control subjects. The range of behavioral disturbances manifested and the relationship between specific abnormalities with the level of cognitive impairment have not been established. Fifty consecutive outpatients with mild (n = 17), moderate (n = 20), and severe (n = 13) AD and 40 age-matched normal controls were evaluated for behavioral abnormalities occurring in the month preceding the interview. The caregivers of the patients and the spouses of the control subjects were interviewed with the Neuropsychiatric Inventory (NPI). The frequency and severity of the following 10 behaviors were assessed: delusions, hallucinations, agitation, dysphoria, anxiety, euphoria, apathy, disinhibition, irritability, and aberrant motor behavior. Correlations among these 10 behaviors and their relationship with cognitive impairment were also investigated. Eighty-eight percent of AD patients had measurable behavioral changes. All 10 behaviors were significantly increased in the AD patients compared with normal subjects. The most common behavior was apathy, which was exhibited by 72% of patients, followed by agitation (60%), anxiety (48%), irritability (42%), dysphoria and aberrant motor behavior (both 38%), disinhibition (36%), delusions (22%), and hallucinations (10%). Agitation, dysphoria, apathy, and aberrant motor behavior were significantly correlated with cognitive impairment.
NEUROLOGY 1996;46: 130-135
This article has been cited by other articles:
![]() |
L. Minati, T. Edginton, M. Grazia Bruzzone, and G. Giaccone Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review American Journal of Alzheimer's Disease and Other Dementias, April 1, 2009; 24(2): 95 - 121. [Abstract] [PDF] |
||||
![]() |
J. J. Jalbert, L. A. Daiello, and K. L. Lapane Dementia of the Alzheimer Type Epidemiol. Rev., November 1, 2008; 30(1): 15 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Bruen, W. J. McGeown, M. F. Shanks, and A. Venneri Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease Brain, September 1, 2008; 131(9): 2455 - 2463. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Clarke, R. van Reekum, M. Simard, D. L. Streiner, D. Conn, T. Cohen, and M. Freedman Apathy in Dementia: Clinical and Sociodemographic Correlates J Neuropsychiatry Clin Neurosci, August 1, 2008; 20(3): 337 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Kilik, R. W. Hopkins, D. Day, C. R. Prince, P. N. Prince, and C. Rows The Progression of Behavior in Dementia: An In-Office Guide for Clinicians American Journal of Alzheimer's Disease and Other Dementias, June 1, 2008; 23(3): 242 - 249. [Abstract] [PDF] |
||||
![]() |
H. H. Feldman MD, C. Jacova PhD, A. Robillard MD, A. Garcia MD PhD, T. Chow MD, M. Borrie MB ChB, H. M. Schipper MD PhD, M. Blair BSc, A. Kertesz MD, and H. Chertkow MD Diagnosis and treatment of dementia: 2. Diagnosis Can. Med. Assoc. J., March 25, 2008; 178(7): 825 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Smith, K. C. Buckwalter, H. Kang, V. Ellingrod, and S. K. Schultz Dementia-Specific Assisted Living: Clinical Factors and Psychotropic Medication Use Journal of the American Psychiatric Nurses Association, March 1, 2008; 14(1): 39 - 49. [Abstract] [PDF] |
||||
![]() |
G. A. Dowling, C. L. Graf, E. M. Hubbard, and J. S. Luxenberg Light Treatment for Neuropsychiatric Behaviors in Alzheimer's Disease West J Nurs Res, December 1, 2007; 29(8): 961 - 975. [Abstract] [PDF] |
||||
![]() |
C. A. Yury and J. E. Fisher Preventing Excess Disability in an Elderly Person With Alzheimer's Disease Clinical Case Studies, August 1, 2007; 6(4): 295 - 306. [Abstract] [PDF] |
||||
![]() |
G. A. Marshall, L. Monserratt, D. Harwood, M. Mandelkern, J. L. Cummings, and D. L. Sultzer Positron Emission Tomography Metabolic Correlates of Apathy in Alzheimer Disease Arch Neurol, July 1, 2007; 64(7): 1015 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Blaszczyk and M. Mathys Treatment of Cognitive Decline and Psychiatric Disturbances Associated With Alzheimer's Dementia Journal of Pharmacy Practice, February 1, 2007; 20(1): 13 - 28. [Abstract] [PDF] |
||||
![]() |
D. E. Clarke, R. v. Reekum, M. Simard, D. L. Streiner, M. Freedman, and D. Conn Apathy in Dementia: An Examination of the Psychometric Properties of the Apathy Evaluation Scale J Neuropsychiatry Clin Neurosci, February 1, 2007; 19(1): 57 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Gibbons, L. Teri, R. G. Logsdon, and S. M. McCurry Assessment of anxiety in dementia: an investigation into the association of different methods of measurement. J Geriatr Psychiatry Neurol, December 1, 2006; 19(4): 202 - 208. [Abstract] [PDF] |
||||
![]() |
J. R. Hodges Alzheimer's centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects. Brain, November 1, 2006; 129(Pt 11): 2811 - 2822. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Friedlander, D. C. Norman, M. E. Mahler, K. M. Norman, and J. A. Yagiela Alzheimer's disease: Psychopathology, medical management and dental implications. J Am Dent Assoc, September 1, 2006; 137(9): 1240 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ortiz, L. J. Fitten, J. L. Cummings, S. Hwang, and M. Fonseca Neuropsychiatric and behavioral symptoms in a community sample of Hispanics with Alzheimer's disease. American Journal of Alzheimer's Disease and Other Dementias, August 1, 2006; 21(4): 263 - 273. [Abstract] [PDF] |
||||
![]() |
A. Kolanowski and M. L. Piven Geropsychiatric Nursing: The State of the Science Journal of the American Psychiatric Nurses Association, April 1, 2006; 12(2): 75 - 99. [Abstract] [PDF] |
||||
![]() |
K. R. Peters, K. Rockwood, S. E. Black, R. Bouchard, S. Gauthier, D. Hogan, A. Kertesz, I. Loy-English, B. L. Beattie, A. D. Sadovnick, et al. Characterizing neuropsychiatric symptoms in subjects referred to dementia clinics Neurology, February 28, 2006; 66(4): 523 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Steffens, M. Maytan, M. J. Helms, and B. L. Plassman Prevalence and clinical correlates of neuropsychiatric symptoms in dementia American Journal of Alzheimer's Disease and Other Dementias, November 1, 2005; 20(6): 367 - 373. [Abstract] [PDF] |
||||
![]() |
J-L Fuh, S-J Wang, and J L Cummings Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1337 - 1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Feldman and M. Woodward The staging and assessment of moderate to severe Alzheimer disease Neurology, September 27, 2005; 65(6_suppl_3): S10 - S17. [Abstract] [Full Text] |
||||
![]() |
J. L. Cummings Neuropsychiatric and behavioral alterations and their management in moderate to severe Alzheimer disease Neurology, September 27, 2005; 65(6_suppl_3): S18 - S24. [Full Text] |
||||
![]() |
S E Starkstein, L Ingram, M L Garau, and R Mizrahi On the overlap between apathy and depression in dementia J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1070 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Landes, S. D. Sperry, and M. E. Strauss Prevalence of Apathy, Dysphoria, and Depression in Relation to Dementia Severity in Alzheimer's Disease J Neuropsychiatry Clin Neurosci, August 1, 2005; 17(3): 342 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sarazin, Y. Stern, C. Berr, A. Riba, M. Albert, J. Brandt, and B. Dubois Neuropsychological predictors of dependency in patients with Alzheimer disease Neurology, March 22, 2005; 64(6): 1027 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Sink, K. F. Holden, and K. Yaffe Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia: A Review of the Evidence JAMA, February 2, 2005; 293(5): 596 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y. Kim, P. A. Yeaman, and R. L. Keene Practical Geriatrics: End-of-Life Care for Persons With Alzheimer's Disease Psychiatr Serv, February 1, 2005; 56(2): 139 - 141. [Full Text] [PDF] |
||||
![]() |
J. N. Laditka, S. B. Laditka, and C. B. Cornman Evaluating hospital care for individuals with Alzheimer's disease using inpatient quality indicators American Journal of Alzheimer's Disease and Other Dementias, January 1, 2005; 20(1): 27 - 36. [Abstract] [PDF] |
||||
![]() |
F. Assal, M. Alarcon, E. C. Solomon, D. Masterman, D. H. Geschwind, and J. L. Cummings Association of the Serotonin Transporter and Receptor Gene Polymorphisms in Neuropsychiatric Symptoms in Alzheimer Disease Arch Neurol, August 1, 2004; 61(8): 1249 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Herrmann, K. L. Lanctot, and L. R. Khan The Role of Norepinephrine in the Behavioral and Psychological Symptoms of Dementia J Neuropsychiatry Clin Neurosci, August 1, 2004; 16(3): 261 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Fishman, R. H. B. Benedict, R. Bakshi, R. Priore, and B. Weinstock-Guttman Construct Validity and Frequency of Euphoria Sclerotica in Multiple Sclerosis J Neuropsychiatry Clin Neurosci, August 1, 2004; 16(3): 350 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Cummings Alzheimer's Disease N. Engl. J. Med., July 1, 2004; 351(1): 56 - 67. [Full Text] [PDF] |
||||
![]() |
H. Feldman, P. Scheltens, E. Scarpini, N. Hermann, P. Mesenbrink, L. Mancione, S. Tekin, R. Lane, and S. Ferris Behavioral symptoms in mild cognitive impairment Neurology, April 13, 2004; 62(7): 1199 - 1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Cummings Use of Cholinesterase Inhibitors in Clinical Practice: Evidence-Based Recommendations Focus, April 1, 2004; 2(2): 239 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
J M Ringman, C Diaz-Olavarrieta, Y Rodriguez, M Chavez, F Paz, J Murrell, M A. Macias, M Hill, and C Kawas Female preclinical presenilin-1 mutation carriers unaware of their genetic status have higher levels of depression than their non-mutation carrying kin J. Neurol. Neurosurg. Psychiatry, March 1, 2004; 75(3): 500 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Corcoran, M. L. Wong, and V. O'Keane Bupropion in the management of apathy J Psychopharmacol, March 1, 2004; 18(1): 133 - 135. [Abstract] [PDF] |
||||
![]() |
P. McMonagle, P. Byrne, and M. Hutchinson Further evidence of dementia in SPG4-linked autosomal dominant hereditary spastic paraplegia Neurology, February 10, 2004; 62(3): 407 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Raskind, E. R. Peskind, L. Truyen, P. Kershaw, and C. V. Damaraju The Cognitive Benefits of Galantamine Are Sustained for at Least 36 Months: A Long-term Extension Trial Arch Neurol, February 1, 2004; 61(2): 252 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Caligiuri, G. Peavy, D. P. Salmon, D. R. Galasko, and L. J. Thal Neuromotor abnormalities and risk for psychosis in Alzheimer's disease Neurology, October 14, 2003; 61(7): 954 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Bassiony and C. G. Lyketsos Delusions and Hallucinations in Alzheimer's Disease: Review of the Brain Decade Psychosomatics, October 1, 2003; 44(5): 388 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hinton, M. Haan, S. Geller, and D. Mungas Neuropsychiatric Symptoms in Latino Elders With Dementia or Cognitive Impairment Without Dementia and Factors That Modify Their Association With Caregiver Depression Gerontologist, October 1, 2003; 43(5): 669 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Knopman, B. F. Boeve, and R. C. Petersen Essentials of the Proper Diagnoses of Mild Cognitive Impairment, Dementia, and Major Subtypes of Dementia Mayo Clin. Proc., October 1, 2003; 78(10): 1290 - 1308. [Abstract] [PDF] |
||||
![]() |
J. Clarimon, J. Bertranpetit, M. Boada, L. Tarraga, and D. Comas HSP70-2 (HSPA1B) is Associated with Noncognitive Symptoms in Late-Onset Alzheimer's Disease J Geriatr Psychiatry Neurol, September 1, 2003; 16(3): 146 - 150. [Abstract] [PDF] |
||||
![]() |
R H. Benedict, I Fishman, M M McClellan, R Bakshi, and B Weinstock-Guttman Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis Multiple Sclerosis, August 1, 2003; 9(4): 393 - 396. [Abstract] [PDF] |
||||
![]() |
R. Moretti, P. Torre, R. M. Antonello, G. Cazzato, S. Griggio, and A. Bava Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: A 24-month follow-up of 68 patients American Journal of Alzheimer's Disease and Other Dementias, July 1, 2003; 18(4): 205 - 214. [Abstract] [PDF] |
||||
![]() |
C. G. Lyketsos, L. DelCampo, M. Steinberg, Q. Miles, C. D. Steele, C. Munro, A. S. Baker, J.-M. E. Sheppard, C. Frangakis, J. Brandt, et al. Treating Depression in Alzheimer Disease: Efficacy and Safety of Sertraline Therapy, and the Benefits of Depression Reduction: The DIADS Arch Gen Psychiatry, July 1, 2003; 60(7): 737 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Religa, H. Laudon, M. Styczynska, B. Winblad, J. Naslund, and V. Haroutunian Amyloid {beta} Pathology in Alzheimer's Disease and Schizophrenia Am J Psychiatry, May 1, 2003; 160(5): 867 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. R. Porter, W. G. Buxton, L. A. Fairbanks, T. Strickland, S. M. O'Connor, S. Rosenberg-Thompson, and J. L. Cummings Frequency and Characteristics of Anxiety Among Patients With Alzheimer's Disease and Related Dementias J Neuropsychiatry Clin Neurosci, May 1, 2003; 15(2): 180 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Ramadan, B. J. Naughton, and R. Prior Correlates of Behavioral Disturbances and Pattern of Psychotropic Medication Use in Five Skilled Nursing Facilities J Geriatr Psychiatry Neurol, March 1, 2003; 16(1): 8 - 14. [Abstract] [PDF] |
||||
![]() |
N.-H. Trinh, J. Hoblyn, S. Mohanty, and K. Yaffe Efficacy of Cholinesterase Inhibitors in the Treatment of Neuropsychiatric Symptoms and Functional Impairment in Alzheimer Disease: A Meta-analysis JAMA, January 8, 2003; 289(2): 210 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.L. Murman, Q. Chen, M.C. Powell, S.B. Kuo, C.J. Bradley, and C.C. Colenda The incremental direct costs associated with behavioral symptoms in AD Neurology, December 10, 2002; 59(11): 1721 - 1729. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Moretti, P. Torre, R. M. Antonello, G. Cazzato, and A. Bava Depression and Alzheimer's disease: Symptom or comorbidity? American Journal of Alzheimer's Disease and Other Dementias, November 1, 2002; 17(6): 338 - 344. [Abstract] [PDF] |
||||
![]() |
D. G. Harwood and D. L. Sultzer "Life Is Not Worth Living": Hopelessness in Alzheimer's Disease J Geriatr Psychiatry Neurol, April 1, 2002; 15(1): 38 - 43. [Abstract] [PDF] |
||||
![]() |
R. E. Tractenberg, M. F. Weiner, and L. J. Thal Estimating the Prevalence of Agitation in Community-Dwelling Persons With Alzheimer's Disease J Neuropsychiatry Clin Neurosci, February 1, 2002; 14(1): 11 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Boyd Behavioral Disturbances Associated with Dementia: Nursing Implications Journal of the American Psychiatric Nurses Association, December 1, 2001; 7(6): S14 - S22. [Abstract] [PDF] |
||||
![]() |
J. R. Shua-Haim, T. Haim, Y. Shi, Y.-H. Kuo, and J. M. Smith Depression among Alzheimer's caregivers: Identifying risk factors American Journal of Alzheimer's Disease and Other Dementias, November 1, 2001; 16(6): 353 - 359. [Abstract] [PDF] |
||||
![]() |
P. J. Neumann, S. S. Araki, A. Arcelus, A. Longo, G. Papadopoulos, K. S. Kosik, K. M. Kuntz, and A. Bhattacharjya Measuring Alzheimer's disease progression with transition probabilities: Estimates from CERAD Neurology, September 25, 2001; 57(6): 957 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. P. Lai, O. -F. Lai, J. Keene, M. M. Esiri, P. T. Francis, T. Hope, and C. P.L.-H. Chen Psychosis of Alzheimer's disease is associated with elevated muscarinic M2 binding in the cortex Neurology, September 11, 2001; 57(5): 805 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Cummings, A. Nadel, D. Masterman, and P. A. Cyrus Efficacy of Metrifonate in Improving the Psychiatric and Behavioral Disturbances of Patients with Alzheimer's Disease J Geriatr Psychiatry Neurol, June 1, 2001; 14(2): 101 - 108. [Abstract] [PDF] |
||||
![]() |
S. I. Bekkelund, I. Kujala, and B. Rosenvinge Unrecognized Dementia in Elderly Patients Admitted to Hospital with Psychiatric Symptoms J Geriatr Psychiatry Neurol, March 1, 2001; 14(1): 7 - 10. [Abstract] [PDF] |
||||
![]() |
L. Ferretti, S. M. McCurry, R. Logsdon, L. Gibbons, and L. Teri Anxiety and Alzheimer's Disease J Geriatr Psychiatry Neurol, March 1, 2001; 14(1): 52 - 58. [Abstract] [PDF] |
||||
![]() |
K. L. Lanctôt, N. Herrmann, and P. Mazzotta Role of Serotonin in the Behavioral and Psychological Symptoms of Dementia J Neuropsychiatry Clin Neurosci, February 1, 2001; 13(1): 5 - 21. [Abstract] [Full Text] |
||||
![]() |
O. L. Lopez, G. Smith, J. T. Becker, C. C. Meltzer, and S. T. DeKosky The Psychotic Phenomenon in Probable Alzheimer's Disease : A Positron Emission Tomography Study J Neuropsychiatry Clin Neurosci, February 1, 2001; 13(1): 50 - 55. [Abstract] [Full Text] |
||||
![]() |
N. B. Farber, E. H. Rubin, J. W. Newcomer, D. A. Kinscherf, J. P. Miller, J. C. Morris, J. W. Olney, and D. W. McKeel Jr Increased Neocortical Neurofibrillary Tangle Density in Subjects With Alzheimer Disease and Psychosis Arch Gen Psychiatry, December 1, 2000; 57(12): 1165 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Minger, M. M. Esiri, B. McDonald, J. Keene, J. Carter, T. Hope, and P. T. Francis Cholinergic deficits contribute to behavioral disturbance in patients with dementia Neurology, November 28, 2000; 55(10): 1460 - 1467. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Tractenberg, M. Patterson, M. F. Weiner, L. Teri, M. Grundman, R. G. Thomas, and L. J. Thal Prevalence of Symptoms on the CERAD Behavior Rating Scale for Dementia in Normal Elderly Subjects and Alzheimer's Disease Patients J Neuropsychiatry Clin Neurosci, November 1, 2000; 12(4): 472 - 479. [Abstract] [Full Text] |
||||
![]() |
J. S. Street, W. S. Clark, K. S. Gannon, J. L. Cummings, F. P. Bymaster, R. N. Tamura, S. J. Mitan, D. L. Kadam, T. M. Sanger, P. D. Feldman, et al. Olanzapine Treatment of Psychotic and Behavioral Symptoms in Patients With Alzheimer Disease in Nursing Care Facilities: A Double-blind, Randomized, Placebo-Controlled Trial Arch Gen Psychiatry, October 1, 2000; 57(10): 968 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bozeat, C. A Gregory, M. A L. Ralph, and J. R Hodges Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J. Neurol. Neurosurg. Psychiatry, August 1, 2000; 69(2): 178 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Ripich, T. Fritsch, E. Ziol, and E. Durand Compensatory strategies in picture description across severity levels in Alzheimer's disease: A longitudinal study American Journal of Alzheimer's Disease and Other Dementias, July 1, 2000; 15(4): 217 - 228. [Abstract] [PDF] |
||||
![]() |
N. Hirono, M. S. Mega, I. D. Dinov, F. Mishkin, and J. L. Cummings Left Frontotemporal Hypoperfusion Is Associated With Aggression in Patients With Dementia Arch Neurol, June 1, 2000; 57(6): 861 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Lyketsos, M. Steinberg, J. T. Tschanz, M. C. Norton, D. C. Steffens, and J. C.S. Breitner Mental and Behavioral Disturbances in Dementia: Findings From the Cache County Study on Memory in Aging Am J Psychiatry, May 1, 2000; 157(5): 708 - 714. [Abstract] [Full Text] |
||||
![]() |
D. I. Kaufer, J. L. Cummings, P. Ketchel, V. Smith, A. MacMillan, T. Shelley, O. L. Lopez, and S. T. DeKosky Validation of the NPI-Q, a Brief Clinical Form of the Neuropsychiatric Inventory J Neuropsychiatry Clin Neurosci, May 1, 2000; 12(2): 233 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. McCarty, D. L. Roth, K. T. Goode, J. E. Owen, L. Harrell, K. Donovan, and W. E. Haley Longitudinal Course of Behavioral Problems During Alzheimer's Disease: Linear Versus Curvilinear Patterns of Decline J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2000; 55(4): 200M - 206. [Abstract] [Full Text] |
||||
![]() |
G. Binetti, J. J. Locascio, S. Corkin, J. P. Vonsattel, and J. H. Growdon Differences Between Pick Disease and Alzheimer Disease in Clinical Appearance and Rate of Cognitive Decline Arch Neurol, February 1, 2000; 57(2): 225 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Ott, K. L. Lapane, and G. Gambassi Gender differences in the treatment of behavior problems in Alzheimer's disease Neurology, January 25, 2000; 54(2): 427 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Judge, C. J. Camp, and S. Orsulic-Jeras Use of Montessori-based activities for clients with dementia in adult day care: Effects on engagement American Journal of Alzheimer's Disease and Other Dementias, January 1, 2000; 15(1): 42 - 46. [Abstract] [PDF] |
||||
![]() |
J. L. Mack, M. B. Patterson, and P. N. Tariot Behavior Rating Scale for Dementia: Development of Test Scales and Presentation of Data for 555 Individuals with Alzheimer's Disease J Geriatr Psychiatry Neurol, December 1, 1999; 12(4): 211 - 223. [Abstract] [PDF] |
||||
![]() |
M. S. Mega, D. M. Masterman, S. M. O'Connor, T. R. Barclay, and J. L. Cummings The Spectrum of Behavioral Responses to Cholinesterase Inhibitor Therapy in Alzheimer Disease Arch Neurol, November 1, 1999; 56(11): 1388 - 1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Aarsland, J. P Larsen, N. G. Lim, C. Janvin, K. Karlsen, E. Tandberg, and J. L Cummings Range of neuropsychiatric disturbances in patients with Parkinson's disease J. Neurol. Neurosurg. Psychiatry, October 1, 1999; 67(4): 492 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Cummings and D. V. Jeste Alzheimer's Disease and Its Management in the Year 2010 Psychiatr Serv, September 1, 1999; 50(9): 1173 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Cummings and D. Knopman Advances in the treatment of behavioral disturbances in Alzheimer's disease Neurology, September 1, 1999; 53(5): 899 - 899. [Full Text] |
||||
![]() |
M. C. Irizarry, S. N. Ghaemi, E. R. Lee-Cherry, T. Gomez-Isla, G. Binetti, B. T. Hyman, and J. H. Growdon Risperidone Treatment of Behavioral Disturbances in Outpatients With Dementia J Neuropsychiatry Clin Neurosci, August 1, 1999; 11(3): 336 - 342. [Abstract] [Full Text] |
||||
![]() |
D. Aarsland, J. P. Larsen, J. L. Cummings, and K. Laake Prevalence and Clinical Correlates of Psychotic Symptoms in Parkinson Disease: A Community-Based Study Arch Neurol, May 1, 1999; 56(5): 595 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. O'Tuama, D. P. Dickstein, R. Neeper, and G. G. Gascon Topical Review: Functional Brain Imaging in Neuropsychiatric Disorders of Childhood J Child Neurol, April 1, 1999; 14(4): 207 - 221. [Abstract] [PDF] |
||||
![]() |
C. Diaz-Olavarrieta, J. L. Cummings, J. Velazquez, and C. Garcia de al Cadena Neuropsychiatric Manifestations of Multiple Sclerosis J Neuropsychiatry Clin Neurosci, February 1, 1999; 11(1): 51 - 57. [Abstract] [Full Text] |
||||
![]() |
N. Hirono, E. Mori, M. Yasuda, T. Imamura, T. Shimomura, M. Hashimoto, S. Tanimukai, H. Kazui, and H. Yamashita Lack of Effect of Apolipoprotein E E4 Allele on Neuropsychiatric Manifestations in Alzheimer's Disease J Neuropsychiatry Clin Neurosci, February 1, 1999; 11(1): 66 - 70. [Abstract] [Full Text] |
||||
![]() |
L. J. Fitten, F. Ortiz, D. W. Siembieda, J. O'Neill, E. Halgren, and A. Fisher Reduction of Motoric Agitation and Restlessness by AF102B and Tacrine in the Macaque J Neuropsychiatry Clin Neurosci, February 1, 1999; 11(1): 79 - 85. [Abstract] [Full Text] |
||||
![]() |
C. G. Lyketsos, C. Steele, E. Galik, A. Rosenblatt, M. Steinberg, A. Warren, and J.-M. Sheppard Physical Aggression in Dementia Patients and Its Relationship to Depression Am J Psychiatry, January 1, 1999; 156(1): 66 - 71. [Abstract] [Full Text] |
||||
![]() |
M. L. Levy, J. L. Cummings, L. A. Fairbanks, D. Masterman, B. L. Miller, A. H. Craig, J. S. Paulsen, and I. Litvan Apathy Is Not Depression J Neuropsychiatry Clin Neurosci, August 1, 1998; 10(3): 314 - 319. [Abstract] [Full Text] |
||||
![]() |
G. Binetti, M. S. Mega, E. Magni, A. Padovani, L. Rozzini, A. Bianchetti, M. Trabucchi, and J. L. Cummings Behavioral Disorders in Alzheimer Disease: A Transcultural Perspective Arch Neurol, April 1, 1998; 55(4): 539 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kaufer, J. L. Cummings, and D. Christine Differential Neuropsychiatric Symptom Responses to Tacrine in Alzheimer's Disease: Relationship to Dementia Severity J Neuropsychiatry Clin Neurosci, February 1, 1998; 10(1): 55 - 63. [Abstract] [Full Text] |
||||
![]() |
G. W. Small, P. V. Rabins, P. P. Barry, N. S. Buckholtz, S. T. DeKosky, S. H. Ferris, S. I. Finkel, L. P. Gwyther, Z. S. Khachaturian, B. D. Lebowitz, et al. Diagnosis and Treatment of Alzheimer Disease and Related Disorders: Consensus Statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society JAMA, October 22, 1997; 278(16): 1363 - 1371. [Abstract] [PDF] |
||||
![]() |
A. Russo-Neustadt and C. W. Cotman Adrenergic Receptors in Alzheimer's Disease Brain: Selective Increases in the Cerebella of Aggressive Patients J. Neurosci., July 15, 1997; 17(14): 5573 - 5580. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Bodick, W. W. Offen, A. I. Levey, N. R. Cutler, S. G. Gauthier, A. Satlin, H. E. Shannon, G. D. Tollefson, K. Rasmussen, F. P. Bymaster, et al. Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease Arch Neurol, April 1, 1997; 54(4): 465 - 473. [Abstract] [PDF] |
||||
![]() |
F. Lopera, A. Ardilla, A. Martinez, L. Madrigal, J. C. Arango-Viana, C. A. Lemere, J. C. Arango-Lasprilla, L. Hincapie, M. Arcos-Burgos, J. E. Ossa, et al. Clinical Features of Early-Onset Alzheimer Disease in a Large Kindred With an E280A Presenilin-1 Mutation JAMA, March 12, 1997; 277(10): 793 - 799. [Abstract] [PDF] |
||||
![]() |
M. L. Levy, B. L. Miller, J. L. Cummings, L. A. Fairbanks, and A. Craig Alzheimer Disease and Frontotemporal Dementias: Behavioral Distinctions Arch Neurol, July 1, 1996; 53(7): 687 - 690. [Abstract] [PDF] |
||||
![]() |
Behavior Changes in Alzheimer's Disease Journal Watch Psychiatry, April 1, 1996; 1996(401): 8 - 8. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |